History of Bioassay Methods

Category	Research
Also known as	bioassay history, biological assays peptides
Last updated	2026-04-14
Reading time	3 min read
Tags	researchbioassayhistorymethodology

Overview

A bioassay measures the biological activity of a substance by applying it to a living system and quantifying the resulting physiological response. Before the advent of radioimmunoassay in 1960, bioassays were the primary tool for characterizing peptide hormones. They determined what the hormone did, how potent it was, and how much was present in tissue extracts.

Classic bioassays included measuring insulin's potency by its hypoglycemic effect in fasted rats or rabbits, oxytocin's potency by milk ejection or uterine contraction in animal tissue, ACTH's potency by cortisol release or adrenal ascorbic acid depletion, and growth hormone's potency by tibial epiphyseal cartilage width in hypophysectomized rats. Each bioassay required standardized preparation of animals, careful dosing, and defined endpoints, along with comparison to reference standards (typically WHO International Standards).

Bioassays have been partly supplanted by immunoassays and mass spectrometry, but they retain an important role in characterizing biological activity — particularly for novel peptides or for confirming that a new formulation, impurity, or degradation product is biologically active (or inactive).

Key Concepts

Reference standard: Internationally standardized preparation used to calibrate assays.
Parallel-line assay: Compares dose-response of unknown and standard; parallel curves imply same biological activity.
Four-point assay: Efficient design using two doses of standard and two of unknown.
Units: Bioassay results are expressed in biological units rather than mass units.
Validation: Assessment of precision, accuracy, and specificity.
In vivo versus in vitro bioassays: Whole-animal versus isolated-tissue systems.

Background

Early endocrinology depended on bioassays because chemical methods could not detect hormones at physiological concentrations. The hypoglycemic rabbit assay, for example, was the standard potency test for insulin through the 1950s and was used by regulatory agencies to certify commercial insulin lots. The isolated rat uterus assay for oxytocin and the anterior pituitary-pregnant mouse bioassay for FSH were similarly standard.

Bioassay development drove some of the great advances in endocrinology. Geoffrey Harris's work on the hypothalamic control of the pituitary relied on bioassays to detect and measure hypothalamic extracts that would later be identified as TRH, GnRH, and other peptides. Viktor Mutt and Erik Jorpes used bioassays to guide purification of gut peptides, yielding CCK, secretin, VIP, and many others.

Strengths and Limitations

Strengths of bioassays:

Direct measurement of biological activity, independent of structural identity.
Detection of novel, structurally unknown activities.
Measurement across species, when sequences vary.
Useful for poorly characterized samples (tissue extracts, combination preparations).

Limitations:

Slow and labor-intensive compared to modern immunoassays.
Animal use raises cost and ethical concerns.
Variability between animals and across laboratories.
Specificity limitations when multiple substances produce similar responses.
Insensitivity for some targets.

Modern Relevance

Although immunoassays and mass spectrometry have replaced bioassays for most routine measurements, cell-based bioassays remain important. Modern applications include:

Receptor activation assays: cAMP, calcium, or reporter gene assays in cell lines expressing the target receptor.
Neutralizing antibody assays: Cell-based assays are often preferred over binding assays to detect clinically relevant neutralizing anti-drug antibodies.
Potency assays: Required for biologic drug lot release.
Investigation of novel modalities: Cell-based bioassays are essential for characterizing new peptide mimetics, biased agonists, and multispecific molecules.

Understanding the history and principles of bioassays is valuable because many modern assay concepts — reference standards, parallel-line analysis, potency expressed relative to a standard — originated in classical bioassay methodology. For related topics, see radioimmunoassay-method and elisa-method.